Episode
France’s biotech ecosystem: science, capital and scale
- Podcast
- BioSpace
- Published
- May 28, 2026
- Duration seconds
- 1260
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/france-s-biotech-ecosystem-science-capital-and-scale/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Ksenija Pavletic , Partner and Chief Commercial Officer, Jeito Capital Thierry Laugel , Managing Partner, Kurma Partners Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.